CompletedPhase 4NCT04999618

A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology

Studying Capillary malformation-arteriovenous malformation

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Center for Vascular Pathology, Moscow
Principal Investigator: Ekaterina M Listovskaya, BSc
The Vascular Anomalies Center (VAC) "Hemangioma",
Intervention: Haemoblock(drug)
Enrollment: 200 enrolled
Eligibility: 18 years · All sexes
Timeline: 2020 – 2021

Study locations (1)

The Vascular Anomalies Center (VAC) "Hemangioma", Moscow, Russia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04999618 on ClinicalTrials.gov

← Back to all trials